|
A
Few Essentials about Hemoccult:
|
| |
|
Hemoccult
products are the only
FOBTs proven through large-scale, randomized
clinical studies to reduce CRC incidence
and mortality.
|
|
Used with
confidence by physicians for over 30 years,
Hemoccult products are supported in over
300 clinical publications and are recommended
by the American Cancer Society as an effective
screening method.
|
|
With fewer
diet restrictions than other FOBT products,
Hemoccult products make it easier for
patients to comply and complete the test.
And with the new Hemoccult ICT there is
no dietary or medicinal restrictions.
|
|
Our annual
triple-slide, take-home FOBT is the least
invasive method available for screening,
and patients can prepare it in the privacy
of their own home. |
|
|
|
Hemoccult
Products |
| |
The original FOBT that is clinically proven
to reduce incidence and mortality due to CRC.
Click
here to view Hemoccult Products. |
|
|
Hemoccult
ICT |
| |
ICT is the next generation of Fecal Occult Blood
Test (iFOBT). This immonochemical- based test
eliminates any diet restrations for the patient,
removes all drug restrictions and is specific
for bleeding in the lower GI, which makes it
a more accurate screen for colorectal cancers.
Hemoccult® ICT Part I (749k)
Hemoccult® ICT Part II (716k)
|
|
|
Hemoccult
SENSA® Products |
| |
ICT is the next generation of Fecal Occult Blood
Test (iFOBT). This immonochemical- based test
eliminates any diet restrations for the patient,
removes all drug restrictions and is specific
for bleeding in the lower GI, which makes it
a more accurate screen for colorectal cancers.
|
|
|
Hemoccult
II® SENSA elite |
| |
Designed to increase patient compliance byproviding
easier patient instructions and sampling, and
offering easier processing for the healthcare
professional.
Click here to view Hemoccult
II SENSA elite. |
|
|
Footnotes:
1. Mandel JS
et al. NEJM 1993;328:1365-1371.
|
|
